Tate & Lyle (LON:BD15) has been given an average recommendation of “Hold” by the nine research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 685.56 ($9.56).
BD15 has been the subject of several analyst reports. Deutsche Bank set a GBX 650 ($9.07) target price on Tate & Lyle and gave the stock a “neutral” rating in a research note on Monday, February 12th. Credit Suisse Group set a GBX 670 ($9.34) price target on Tate & Lyle and gave the stock a “neutral” rating in a report on Thursday, February 8th. Societe Generale set a GBX 680 ($9.48) price target on Tate & Lyle and gave the stock a “buy” rating in a report on Friday, February 9th. Kepler Capital Markets set a GBX 630 ($8.79) price target on Tate & Lyle and gave the stock a “buy” rating in a report on Wednesday, February 14th. Finally, Goldman Sachs set a GBX 695 ($9.69) price target on Tate & Lyle and gave the stock a “neutral” rating in a report on Wednesday, February 7th.
LON BD15 traded up GBX 8.50 ($0.12) during trading hours on Monday, hitting GBX 120 ($1.67). The company’s stock had a trading volume of 12,000 shares, compared to its average volume of 617. Tate & Lyle has a twelve month low of GBX 102.50 ($1.43) and a twelve month high of GBX 105.50 ($1.47).
Tate & Lyle Company Profile
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.